Munes Albadaineh
Role not yet determined Is this you? Add your title
Also affiliated: King Abdullah Medical City (2013–2014)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Munes Albadaineh's research has focused on pharmacologic interactions and clinical applications of various agents. Publications include work on the potentially life-threatening combination of methotrexate and trimethoprim-sulfamethoxazole, practical considerations for high-dose methotrexate therapy, and the role of oncology clinical pharmacists in patient care. Albadaineh has also investigated intraperitoneal chemotherapy and reviewed the literature on percutaneous pericardiocentesis. More recent work explores the safety and efficacy of enoxaparin in percutaneous coronary intervention, cardiovascular outcomes associated with SGLT2 inhibitor and GLP1 receptor agonist therapy in type 2 diabetes, and trends in interventional cardiology fellowship positions.
With an h-index of 4 and 91 total citations across 6 publications, Albadaineh has collaborated with researchers at the University of Arkansas for Medical Sciences, including Malek Alaiwah, Omar Alqaisi, Robert Spraggins, and Landon Bruich, with whom multiple shared publications exist. Albadaineh's scholarship metrics indicate recent activity, with publications extending to 2026.
Metrics
- h-index: 4
- Publications: 6
- Citations: 91
Selected Publications
-
The Growing Concern of Unfilled Interventional Cardiology Fellowships: Causes, Trends, and the Path Forward (2026)
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience (2026)
-
Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)
-
Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes (2025)
-
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)
-
SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
-
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024)
-
Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)
-
100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
Collaboration Network
Top Collaborators
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
Showing 5 of 6 shared publications
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience
- Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
Similar Researchers
Based on overlapping research topics